Spirair Advances Office-Based Solution to Widespread Nasal Issue During Biodesign Summer Extension Program

Good ideas can come from anywhere, but as the Fogarty Institute has found over and over, the Stanford Biodesign Summer Extension program is a rich source for innovation. That’s why it has partnered with Stanford Biodesign to give promising projects even more hands-on expertise, including one-on-one and group mentoring, recommendations specialized to the company’s unique needs,

Fogarty Institute Helps Advance Promising Projects from Stanford Biodesign

For several years, the Fogarty Institute has partnered with Stanford Biodesign’s Summer Extension program, which provides funding to help advance promising projects. The Institute offers these young companies its signature hands-on mentoring from each member of the executive team, in addition to a dedicated mentor, along with a comprehensive development plan and opportunity to participate in educational workshops tailored to their specific needs.

Q&A with Denise Zarins, Fogarty Institute’s Chief Technical Officer

As we look ahead to the eventual easing of shelter-in-place requirements, companies are considering how to tackle the next phase of re-entry. Recently, we had the pleasure of hearing from Denise Zarins, Zach Edmonds, MD, and Gayle Kuokka, the dedicated re-entry leads for the Fogarty Institute, who held a collaborative discussion with our companies-in-residence and outside healthtech startups.

Commercialization and Reimbursement are Topics of the Fogarty Institute’s First Virtual Workshop

To effectively introduce a new product to market and ensure it is widely adopted, medtech companies must consider the many facets of their go-to-market strategy from the earliest days of product development.

This was the message of the Fogarty Institute’s third-annual educational workshop focused on commercialization. The three-part seminar series, being presented virtually to adhere to COVID restrictions,

Raydiant Oximetry Executive Team Spearheads the Launch of Ventilator Company Respirana

When Neil Ray, MD, founder and CEO of FII graduate Raydiant Oximetry and a board-certified anesthesiologist, learned about the global shortage of ventilators early in the COVID-19 crisis, he immediately considered ways that he, his colleagues and others in the Silicon Valley medtech ecosystem could help.

He first reached out to Russ DeLonzor,

Q&A with Mark Leahey, MDMA CEO and Fogarty Institute Board Member

As the Medical Device Manufacturers Association (MDMA) continues to take the lead in representing the interest of medtech companies, we wanted to sit down and talk with president and CEO, and Fogarty Institute board member, Mark Leahey, about the current landscape. MDMA is an incredibly nimble and effective organization – just like its constituents – and has been a beacon during the COVID-19 crisis,

UCSF-Stanford Pediatric Device Consortium Pitch Competition a Virtual Success

Innovation can’t be stopped by a quarantine. The 2020 annual UCSF-Stanford Pediatric Device Consortium Pitch Competition, originally scheduled to take place at the Stanford University School of Medicine, went off seamlessly in a virtual, but still highly interactive format last month.

The Pediatric Device Consortium (PDC) felt it was critical to hold the competition as planned in order to support the much-needed development of health technologies for children,

New Fogarty Company Addresses $1.75 Billion Chronic Sinusitis Market

Imagine having a really bad cold that never goes away—congestion, runny nose, facial pressure, headache and loss of smell for more than three months. That’s what it feels like to the more than 36 million people in the U.S. who suffer from chronic rhinosinusitis (CRS), a persistent inflammatory condition of the nasal and sinus cavity lining.

START TYPING AND PRESS ENTER TO SEARCH